Deborah H. Telman

Deborah H. Telman (board member) discloses dealings in 3 companies, chiefly Gilead Sciences, Inc., AtriCure, Inc. and Organon & Co. Between 15 June 2021 and 12 November 2025, the trades on record add up to 28 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 13 November 2025 with an option exercise (€1.1M) in Gilead Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.